{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:15:31Z","timestamp":1794410131646,"version":"4.9.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS114143"],"award-info":[{"award-number":["U01NS114143"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["5P30ES013508."],"award-info":[{"award-number":["5P30ES013508."]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["5P30ES013508."],"award-info":[{"award-number":["5P30ES013508."]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00415-023-12118-x","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T13:02:27Z","timestamp":1702040547000},"page":"1844-1849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohort"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7168-214X","authenticated-orcid":false,"given":"David R.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerapat","family":"Rojsajjakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"Subramony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medina","family":"Keita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementina","family":"Mesaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"12118_CR1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Canizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocozza S, Koenig M, Pandolfo M (1996) Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423\u20131427","journal-title":"Science"},{"key":"12118_CR2","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","volume":"335","author":"A Durr","year":"1996","unstructured":"Durr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, Mandel JL, Brice A, Koenig M (1996) Clinical and genetic abnormalities in patients with Friedreich\u2019s ataxia. N Engl J Med 335:1169\u20131175","journal-title":"N Engl J Med"},{"key":"12118_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/B978-0-444-51892-7.00017-6","volume":"103","author":"M Pandolfo","year":"2012","unstructured":"Pandolfo M (2012) Friedreich ataxia. Handb Clin Neurol 103:275\u2013294","journal-title":"Handb Clin Neurol"},{"key":"12118_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ymgme.2007.05.009","volume":"92","author":"NE Babady","year":"2007","unstructured":"Babady NE, Carelle N, Wells RD, Rouault TA, Hirano M, Lynch DR, Delatycki MB, Wilson RB, Isaya G, Puccio H (2007) Advancements in the pathophysiology of Friedreich\u2019s Ataxia and new prospects for treatments. Mol Genet Metab 92:23\u201335","journal-title":"Mol Genet Metab"},{"issue":"Suppl 1","key":"12118_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-009-1002-3","volume":"256","author":"M Pandolfo","year":"2009","unstructured":"Pandolfo M (2009) Friedreich ataxia: the clinical picture. J Neurol 256(Suppl 1):3\u20138","journal-title":"J Neurol"},{"key":"12118_CR6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24249","volume":"76","author":"YK Chutake","year":"2014","unstructured":"Chutake YK, Lam C, Costello WN, Anderson M, Bidichandani SI (2014) Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length. Ann Neurol 76:522\u2013528","journal-title":"Ann Neurol"},{"key":"12118_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138437","volume":"10","author":"YK Chutake","year":"2015","unstructured":"Chutake YK, Costello WN, Lam CC, Parikh AC, Hughes TT, Michalopulos MG, Pook MA, Bidichandani SI (2015) FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia. PLoS ONE 10:e0138437","journal-title":"PLoS ONE"},{"key":"12118_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U","volume":"45","author":"M Cossee","year":"1999","unstructured":"Cossee M, Durr A, Schmitt M, Dahl N, Trouillas P, Allinson P, Kostrzewa M, Nivelon-Chevallier A, Gustavson KH, Kohlschutter A, Muller U, Mandel JL, Brice A, Koenig M, Cavalcanti F, Tammaro A, De Michele G, Filla A, Cocozza S, Labuda M, Montermini L, Poirier J, Pandolfo M (1999) Friedreich\u2019s ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol 45:200\u2013206","journal-title":"Ann Neurol"},{"key":"12118_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.24595","volume":"79","author":"CA Galea","year":"2016","unstructured":"Galea CA, Huq A, Lockhart PJ, Tai G, Corben LA, Yiu EM, Gurrin LC, Lynch DR, Gelbard S, Durr A, Pousset F, Parkinson M, Labrum R, Giunti P, Perlman SL, Delatycki MB, Evans-Galea MV (2016) Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia. Ann Neurol 79:485\u2013495","journal-title":"Ann Neurol"},{"key":"12118_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/jnnp.68.5.661","volume":"68","author":"ML McCormack","year":"2000","unstructured":"McCormack ML, Guttmann RP, Schumann M, Farmer JM, Stolle CA, Campuzano V, Koenig M, Lynch DR (2000) Frataxin point mutations in two patients with Friedreich\u2019s ataxia and unusual clinical features. J Neurol Neurosurg Psychiatry 68:661\u2013664","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12118_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/acn3.225","volume":"2","author":"M Lazaropoulos","year":"2015","unstructured":"Lazaropoulos M, Dong Y, Clark E, Greeley NR, Seyer LA, Brigatti KW, Christie C, Perlman SL, Wilmot GR, Gomez CM, Mathews KD, Yoon G, Zesiewicz T, Hoyle C, Subramony SH, Brocht AF, Farmer JM, Wilson RB, Deutsch EC, Lynch DR (2015) Frataxin levels in peripheral tissue in Friedreich ataxia. Ann Clin Transl Neurol 2:831\u2013842","journal-title":"Ann Clin Transl Neurol"},{"key":"12118_CR12","doi-asserted-by":"publisher","first-page":"17043","DOI":"10.1038\/s41598-018-35346-y","volume":"8","author":"L Guo","year":"2018","unstructured":"Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Mesaros C, Lynch DR, Blair IA (2018) Characterization of a new N-terminally acetylated extra-mitochondrial isoform of frataxin in human erythrocytes. Sci Rep 8:17043","journal-title":"Sci Rep"},{"key":"12118_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.874768","volume":"16","author":"Q Wang","year":"2022","unstructured":"Wang Q, Laboureur L, Weng L, Eskenazi NM, Hauser LA, Mesaros C, Lynch DR, Blair IA (2022) Simultaneous Quantification of Mitochondrial Mature Frataxin and Extra-Mitochondrial Frataxin Isoform E in Friedreich\u2019s Ataxia Blood. Front Neurosci 16:874768","journal-title":"Front Neurosci"},{"key":"12118_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1136\/jnnp-2013-306788","volume":"85","author":"EC Deutsch","year":"2014","unstructured":"Deutsch EC, Oglesbee D, Greeley NR, Lynch DR (2014) Usefulness of frataxin immunoassays for the diagnosis of Friedreich ataxia. J Neurol Neurosurg Psychiatry 85:994\u20131002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12118_CR15","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1373\/clinchem.2013.207472","volume":"59","author":"D Oglesbee","year":"2013","unstructured":"Oglesbee D, Kroll C, Gakh O, Deutsch EC, Lynch DR, Gavrilova R, Tortorelli S, Raymond K, Gavrilov D, Rinaldo P, Matern D, Isaya G (2013) High-throughput immunoassay for the biochemical diagnosis of Friedreich ataxia in dried blood spots and whole blood. Clin Chem 59:1461\u20131469","journal-title":"Clin Chem"},{"key":"12118_CR16","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1002\/mds.23789","volume":"26","author":"W Nachbauer","year":"2011","unstructured":"Nachbauer W, Wanschitz J, Steinkellner H, Eigentler A, Sturm B, Hufler K, Scheiber-Mojdehkar B, Poewe W, Reindl M, Boesch S (2011) Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia. Mov Disord 26:1935\u20131938","journal-title":"Mov Disord"},{"key":"12118_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ymgme.2010.07.001","volume":"101","author":"EC Deutsch","year":"2010","unstructured":"Deutsch EC, Santani AB, Perlman SL, Farmer JM, Stolle CA, Marusich MF, Lynch DR (2010) A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Mol Genet Metab 101:238\u2013245","journal-title":"Mol Genet Metab"},{"key":"12118_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ymgme.2008.03.019","volume":"94","author":"JH Willis","year":"2008","unstructured":"Willis JH, Isaya G, Gakh O, Capaldi RA, Marusich MF (2008) Lateral-flow immunoassay for the frataxin protein in Friedreich\u2019s ataxia patients and carriers. Mol Genet Metab 94:491\u2013497","journal-title":"Mol Genet Metab"},{"key":"12118_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.aca.2009.11.036","volume":"659","author":"H Steinkellner","year":"2010","unstructured":"Steinkellner H, Scheiber-Mojdehkar B, Goldenberg H, Sturm B (2010) A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels. Anal Chim Acta 659:129\u2013132","journal-title":"Anal Chim Acta"},{"key":"12118_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2019.07.001","volume":"474","author":"L Weng","year":"2019","unstructured":"Weng L, Wang Q, Yu S, Yang X, Lynch DR, Mesaros C, Blair IA (2019) Evaluation of antibodies for western blot analysis of frataxin protein isoforms. J Immunol Methods 474:112629","journal-title":"J Immunol Methods"},{"key":"12118_CR21","doi-asserted-by":"publisher","first-page":"15788","DOI":"10.1038\/s41598-020-72884-w","volume":"10","author":"L Weng","year":"2020","unstructured":"Weng L, Laboureur L, Wang Q, Guo L, Xu P, Gottlieb L, Lynch DR, Mesaros C, Blair IA (2020) Extra-mitochondrial mouse frataxin and its implications for mouse models of Friedreich\u2019s ataxia. Sci Rep 10:15788","journal-title":"Sci Rep"},{"key":"12118_CR22","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1021\/acs.analchem.7b04590","volume":"90","author":"L Guo","year":"2018","unstructured":"Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Rocha AG, Dancis A, Mesaros C, Lynch DR, Blair IA (2018) Liquid chromatography-high resolution mass spectrometry analysis of platelet frataxin as a protein biomarker for the rare disease Friedreich\u2019s Ataxia. Anal Chem 90:2216\u20132223","journal-title":"Anal Chem"},{"key":"12118_CR23","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1021\/acs.analchem.3c00091","volume":"95","author":"T Rojsajjakul","year":"2023","unstructured":"Rojsajjakul T, Wu L, Grady CB, Hwang WT, Mesaros C, Lynch DR, Blair IA (2023) Liquid Chromatography-Mass Spectrometry Analysis of Frataxin Proteoforms in Whole Blood as Biomarkers of the Genetic Disease Friedreich\u2019s Ataxia. Anal Chem 95:4251\u20134260","journal-title":"Anal Chem"},{"key":"12118_CR24","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/01.wnl.0000218155.46739.90","volume":"66","author":"DR Lynch","year":"2006","unstructured":"Lynch DR, Farmer JM, Tsou AY, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Wilson RB, Balcer LJ (2006) Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology 66:1711\u20131716","journal-title":"Neurology"},{"key":"12118_CR25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/mds.22912","volume":"25","author":"LS Friedman","year":"2010","unstructured":"Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Balcer LJ, Wilson RB, Lynch DR (2010) Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord 25:426\u2013432","journal-title":"Mov Disord"},{"key":"12118_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1212\/NXG.0000000000000371","volume":"5","author":"C Rummey","year":"2019","unstructured":"Rummey C, Corben LA, Delatycki MB, Subramony SH, Bushara K, Gomez CM, Hoyle JC, Yoon G, Ravina B, Mathews KD, Wilmot G, Zesiewicz T, Perlman S, Farmer JM, Lynch DR (2019) Psychometric properties of the Friedreich Ataxia Rating Scale. Neurol Genet 5:371","journal-title":"Neurol Genet"},{"key":"12118_CR27","volume-title":"Williams manual of hematology","author":"MA Lichtman","year":"2022","unstructured":"Lichtman MA, Kaushansky K, Prchal JT, Levi MM, Burns LJ, Linch DC (2022) Williams manual of hematology. MgGraw Hill, New York"},{"key":"12118_CR28","doi-asserted-by":"crossref","unstructured":"Palka T, Koteja PM, Tota L, Rydzik L, Kopanska M, Kaczorowska I, Javdaneh N, Mikulakova W, Wolski H, Ambrozy T (2023) The Influence of Various Hydration Strategies (Isotonic, Water, and No Hydration) on Hematological Indices, Plasma Volume, and Lactate Concentration in Young Men during Prolonged Cycling in Elevated Ambient Temperatures. Biology (Basel) 12","DOI":"10.3390\/biology12050687"},{"key":"12118_CR29","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jacbts.2022.04.005","volume":"7","author":"RM Payne","year":"2022","unstructured":"Payne RM (2022) Cardiovascular Research in Friedreich ataxia: unmet needs and opportunities. JACC Basic Transl Sci 7:1267\u20131283","journal-title":"JACC Basic Transl Sci"},{"key":"12118_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189990","volume":"12","author":"A Long","year":"2017","unstructured":"Long A, Napierala JS, Polak U, Hauser L, Koeppen AH, Lynch DR, Napierala M (2017) Somatic instability of the expanded GAA repeats in Friedreich\u2019s ataxia. PLoS ONE 12:e0189990","journal-title":"PLoS ONE"},{"key":"12118_CR31","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1177\/0883073812448460","volume":"27","author":"EC Deutsch","year":"2012","unstructured":"Deutsch EC, Seyer LA, Perlman SL, Yu J, Lynch DR (2012) Clinical monitoring in a patient with Friedreich ataxia and osteogenic sarcoma. J Child Neurol 27:1159\u20131163","journal-title":"J Child Neurol"},{"key":"12118_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063958","volume":"8","author":"HL Plasterer","year":"2013","unstructured":"Plasterer HL, Deutsch EC, Belmonte M, Egan E, Lynch DR, Rusche JR (2013) Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich\u2019s ataxia. PLoS ONE 8:e63958","journal-title":"PLoS ONE"},{"key":"12118_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/ane.12337","volume":"132","author":"L Seyer","year":"2015","unstructured":"Seyer L, Greeley N, Foerster D, Strawser C, Gelbard S, Dong Y, Schadt K, Cotticelli MG, Brocht A, Farmer J, Wilson RB, Lynch DR (2015) Open-label pilot study of interferon gamma-1b in Friedreich ataxia. Acta Neurol Scand 132:7\u201315","journal-title":"Acta Neurol Scand"},{"key":"12118_CR34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/acn3.731","volume":"6","author":"DR Lynch","year":"2019","unstructured":"Lynch DR, Hauser L, McCormick A, Wells M, Dong YN, McCormack S, Schadt K, Perlman S, Subramony SH, Mathews KD, Brocht A, Ball J, Perdok R, Grahn A, Vescio T, Sherman JW, Farmer JM (2019) Randomized, double-blind, placebo-controlled study of interferon-gamma 1b in Friedreich Ataxia. Ann Clin Transl Neurol 6:546\u2013553","journal-title":"Ann Clin Transl Neurol"},{"key":"12118_CR35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1586\/14737175.2014.939173","volume":"14","author":"CJ Strawser","year":"2014","unstructured":"Strawser CJ, Schadt KA, Lynch DR (2014) Therapeutic approaches for the treatment of Friedreich\u2019s ataxia. Expert Rev Neurother 14:949\u2013957","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"12118_CR36","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s42003-023-05472-z","volume":"6","author":"T Rojsajjakul","year":"2023","unstructured":"Rojsajjakul T, Hordeaux JJ, Chaudhury GR, Hinderer CJ, Mesaros C, Wilson JM, Blair IA (2023) Quantification of human mature frataxin protein expression in nonhuman primate hearts after gene therapy. Commun Biol. 6(1):1093","journal-title":"Commun Biol."}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12118-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-12118-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12118-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:08:37Z","timestamp":1711548517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-12118-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["12118"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-12118-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]},"assertion":[{"value":"25 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures were approved by the Children\u2019s Hospital of Philadelphia (CHOP) IRB and conducted in line with the ethical rules for data collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard statement"}}]}}